Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
about
Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.KNOWLEDGE DRIVEN BINNING AND PHEWAS ANALYSIS IN MARSHFIELD PERSONALIZED MEDICINE RESEARCH PROJECT USING BIOBINCombination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.Functional polymorphisms of xenobiotics metabolizing enzymes-a research topic.Progressing Preemptive Genotyping of CYP2C19 Allelic Variants for Sickle Cell Disease Patients.Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.
P2860
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@ast
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@en
type
label
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@ast
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@en
prefLabel
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@ast
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@en
P2860
P356
P1476
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
@en
P2093
Su-Jun Lee
P2860
P356
10.3389/FGENE.2012.00318
P577
2012-01-01T00:00:00Z